Streptococcus pneumoniae
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
| Ampicillin | + |
Imipenem | + |
|
| Azithromycin | 85 |
Levofloxacin | 99 |
|
| Aztreonam | - |
Meropenem | + |
|
| Cefazolin | + |
Moxifloxacin | +
|
|
| Cefepime | + |
Nitrofurantoin | &
|
|
| Ceftazidime | +/- |
Oxacillin/Naf | + |
|
| Ceftriaxone | 89 |
Penicillin | 84 |
|
| Cefuroxime | + |
Piperacillin | +
|
|
| Ciprofloxacin | +/- |
Piperacillin/tazo | + |
|
| Clarithromycin | 60 |
Ticarcillin/Clav | + |
|
| Clindamycin | 80 |
Tobramycin | - |
|
| Doxycycline | 81 |
TMP/SMX | 76 |
|
| Erythromycin | 61 |
Unasyn/Aug | 100 |
|
| Gentamicin | - |
Vancomycin | 100 |
|
Comments: Susceptibility breakpoints differ for meningeal vs non-meningeal pneumococcal isolates. Check with your micro lab.
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
